EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Correlation analysis of serum tgf-bbp2 and tnfsf2 levels with the severity and predictive value of chronic heart failure patients

Yanzi Liu, Shidian Zhu, Wenyu Bu, Yuzhu Fang, Xiaochan Wang, Fuming Liu

Journal of Medical Biochemistry · 2026 · 45 (7) · 1615-1622

DOI: 10.5937/jomb0-64661 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Biochemistry, 2026. Verfasst von Yanzi Liu und 5 weiteren Autor:innen. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work was financially supported by the Young Scientists Fund of the National Natural Science Foundation of China, This work was financially supported by the Key Project of Jiangsu Provincial Health and Health Commission, This work was financially supported by the Postgraduate Research and Practice Innovation Program of Jiangsu Province.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To explore the correlations between serum Transforming Growth Factor Beta Binding Protein 2 (TGFbbp2) and Tumour Necrosis Factor Ligand Superfamily Member 2 (TNFSF2) and the severity of chronic heart failure (CHF) in patients, as well as their predictive value for adverse prognosis.

Methods

A retrospective analysis was conducted of 240 CHF patients admitted to a particular hospital between January 2023 and December 2025. The New York Heart Association (NYHA) cardiac function grades on admission were used to categorise patients into three groups: severe (n=70), moderate (n=80), and mild (n=90). Based on the incidence of major cardiovascular adverse events (MACEs), patients were divided into two groups after 1-year follow-up: a favourable-prognosis group (n=200) and a poor-prognosis group (n=40). The levels of serum TGF-bbp2, TNFSF2, and myocardial injury markers [cardiac troponin (cTnT), creatine kinase isoenzyme (CK-MB), and lactate dehydrogenase (LDH)] and cardiac function indicators [left ventricular ejection fraction (LVEF), left ventricular end-diastolic volume (LVEDV), and left ventricular end-systolic volume (LVESV)] were compared among the three groups and among patients with different prognoses. The correlations among serum TGF-bbp2, TNFSF2, myocardial injury markers, and cardiac function indicators were analysed using Pearson’s correlation coefficient. ROC curves were built to examine the predictive value of blood TGF-bbp2 and TNFSF2 for the poor prognosis of CHF patients.

Results

The blood levels of TGF-bbp2, TNFSF2, cTnT, CK-MB, LDH, LVEDV, and LVESV in the severe group were greater than those in the moderate and mild groups, whereas the LVEF was lower than that in the moderate and mild groups. P<0.05 meant that each of these differences was statistically significant. The serum levels of TGFbbp2 and TNFSF2 were positively correlated with cTnT, CK-MB, LDH, LVEDV, and LVESV (r TGF-bbp2=0.342, 0.354, 0.341, 0.348, 0.340; r TNFSF2=0.359, 0.352, 0.351, 0.357, 0.355; all P<0.05) and negatively correlated with LVEF (r TGF-bbp2=-0.258; r TNFSF2=-0.240; all P<0.05). TGF-bbp2 and TNFSF2 serum levels were substantially higher in the poor-prognosis group than in the good-prognosis group (P<0.05). The AUCs for serum TGF-bbp2 and TNFSF2 in predicting the poor prognosis of CHF patients were 0.861 and 0.869, respectively. The combined AUC was 0.955, with a sensitivity of 90.57% and a specificity of 80.34%.

Conclusion

Serum TGF-bbp2 and TNFSF2 levels are positively correlated with disease severity in patients with CHF. The combined detection of these levels can achieve early prediction of poor patient prognosis.

Förderung

  • This work was financially supported by the Young Scientists Fund of the National Natural Science Foundation of China
  • This work was financially supported by the Key Project of Jiangsu Provincial Health and Health Commission
  • This work was financially supported by the Postgraduate Research and Practice Innovation Program of Jiangsu Province

Zitieren

APA

Liu, Y., Zhu, S., Bu, W., Fang, Y., Wang, X., & Liu, F. (2026). Correlation analysis of serum tgf-bbp2 and tnfsf2 levels with the severity and predictive value of chronic heart failure patients. Journal of Medical Biochemistry, 45(7), 1615-1622. https://doi.org/10.5937/jomb0-64661

Vancouver

Liu Y, Zhu S, Bu W, Fang Y, Wang X, Liu F. Correlation analysis of serum tgf-bbp2 and tnfsf2 levels with the severity and predictive value of chronic heart failure patients. Journal of Medical Biochemistry. 2026;45(7):1615-1622. doi:10.5937/jomb0-64661

BibTeX
@article{Liu2026,
  author = {Liu, Yanzi and Zhu, Shidian and Bu, Wenyu and Fang, Yuzhu and Wang, Xiaochan and Liu, Fuming},
  title = {Correlation analysis of serum tgf-bbp2 and tnfsf2 levels with the severity and predictive value of chronic heart failure patients},
  journal = {Journal of Medical Biochemistry},
  year = {2026},
  volume = {45},
  number = {7},
  pages = {1615--1622},
  doi = {10.5937/jomb0-64661}
}
Kostenlos starten →